Your browser doesn't support javascript.
loading
A content analysis of parents' reflections on pathogenic and uncertain pediatric oncology germline sequencing results.
Howard Sharp, Katianne M; Clark, Mary Egan; Jurbergs, Niki; Ouma, Annastasia; Harrison, Lynn; Taylor, Leslie; Hamilton, Kayla; McGee, Rose B; Nuccio, Regina; Hines-Dowell, Stacy; Gattuso, Jami S; Pritchard, Michelle; Mandrell, Belinda; Tercyak, Kenneth P; Johnson, Liza-Marie; Nichols, Kim E.
Afiliación
  • Howard Sharp KM; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 740, Memphis, TN, 38105, USA. Katianne.sharp@stjude.org.
  • Clark ME; Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Jurbergs N; Present address: Cancer Predisposition, Division of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Ouma A; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 740, Memphis, TN, 38105, USA.
  • Harrison L; Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Taylor L; Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Hamilton K; Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • McGee RB; Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Nuccio R; Present address: Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
  • Hines-Dowell S; Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Gattuso JS; Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Pritchard M; Present address: Concert Genetics, Franklin, TN, USA.
  • Mandrell B; Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Tercyak KP; Division of Nursing Research, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Johnson LM; Division of Nursing Research, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Nichols KE; Division of Nursing Research, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Fam Cancer ; 2024 Sep 20.
Article en En | MEDLINE | ID: mdl-39302531
ABSTRACT
Germline genomic sequencing is increasingly integrated into pediatric cancer care, with pathogenic cancer-predisposing variants identified among 5-18% of affected children and variants of uncertain significance (VUS) in up to 70%. Given the potential medical implications for children and their families, parents' psychosocial responses to learning results are important to understand. Parents of children with cancer who learned their children's germline pathogenic or VUS results following paired tumor and germline genomic sequencing described their cognitive and affective responses to results in an open-ended write-in question after disclosure (M = 10 months post-disclosure; range = 1-28). Responses were coded and categorized using content analysis, then compared across results using chi-square and Fisher's exact test. Parents of children with pathogenic (n = 9), VUS (n = 52), and pathogenic plus VUS results (n = 9) described negative emotions, positive reactions, mixed emotions (i.e., positive and negative emotions), and neutral reactions. Negative emotions were described significantly more frequently with pathogenic results than VUS only (χ2 = 5.19; p = .02), with peace of mind and empowerment only described for those with VUS. Parents also described approach(es) to coping (e.g., faith, plan of action) and reactions specific to the uncertainty of VUS (e.g., disappointment at no explanation for cancer etiology). A subset with VUS described decreasing worry/distress with increased understanding of results, whereas others displayed misconceptions regarding VUS. Screening for emotional adjustment is warranted for parents of children with cancer receiving pathogenic germline results, and screening for understanding is warranted with VUS. Findings highlight the importance of pre-and posttest genetic counseling.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos